LUMEXIA methyl aminolevulinate 160 mg/g cream tube Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lumexia methyl aminolevulinate 160 mg/g cream tube

galderma australia pty ltd - methyl aminolevulinate hydrochloride, quantity: 200 mg/g (equivalent: methyl aminolevulinate, qty 160 mg/g) - cream - excipient ingredients: self-emulsifying glyceryl monostearate; cetostearyl alcohol; peg-40 stearate; methyl hydroxybenzoate; propyl hydroxybenzoate; disodium edetate; glycerol; white soft paraffin; cholesterol; isopropyl myristate; arachis oil; almond oil; oleyl alcohol; purified water - treatment of thin or non-hyperkeratotic and non-pigmented actinic keratoses on the face and scalp when other registered therapies are unacceptable. primary treatment of superficial and/or nodular basal cell carcinoma where surgery is considered inappropriate. treatment of biopsy-proven squamous cell carcinoma in situ (bowen's disease), where surgery is considered inappropriate. lumexia is indicated in adults above 18 years of age.

METVIX methyl aminolevulinate 160mg/g cream tube Austrália - inglês - Department of Health (Therapeutic Goods Administration)

metvix methyl aminolevulinate 160mg/g cream tube

galderma australia pty ltd - methyl aminolevulinate hydrochloride, quantity: 200 mg/g (equivalent: methyl aminolevulinate, qty 160 mg/g) - cream - excipient ingredients: self-emulsifying glyceryl monostearate; cetostearyl alcohol; peg-40 stearate; methyl hydroxybenzoate; propyl hydroxybenzoate; disodium edetate; glycerol; white soft paraffin; cholesterol; isopropyl myristate; arachis oil; almond oil; oleyl alcohol; purified water - treatment of thin or non-hyperkeratotic and non-pigmented actinic keratoses on the face and scalp when other registered therapies are unacceptable. primary treatment of superficial and/or nodular basal cell carcinoma where surgery is considered inappropriate. treatment of biopsy-proven squamous cell carcinoma in situ (bowen's disease), where surgery is considered inappropriate. metvix is indicated in adults above 18 years of age.

EPIDUO FORTE adapalene/benzoyl peroxide 0.3%/2.5% gel tube Austrália - inglês - Department of Health (Therapeutic Goods Administration)

epiduo forte adapalene/benzoyl peroxide 0.3%/2.5% gel tube

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).

EPIDUO FORTE adapalene/benzoyl peroxide 0.3%/2.5% gel bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

epiduo forte adapalene/benzoyl peroxide 0.3%/2.5% gel bottle

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).

Skin moisturizing/barrier dressing Austrália - inglês - Department of Health (Therapeutic Goods Administration)

skin moisturizing/barrier dressing

galderma australia pty ltd - 46206 - skin moisturizing/barrier dressing - provides moisture. used to alleviate conditions such as dry, irritated, flaky or itchy skin. alleviates the symptoms of eczema. helps restore skin barrier

Skin exfoliant, professional Austrália - inglês - Department of Health (Therapeutic Goods Administration)

skin exfoliant, professional

galderma australia pty ltd - 47377 - skin exfoliant, professional - intended to prepare the skin for the treatment with metvix cream.

CLOBEX Shampoo Austrália - inglês - Department of Health (Therapeutic Goods Administration)

clobex shampoo

galderma australia pty ltd - clobetasol propionate -

Eryacne Austrália - inglês - Department of Health (Therapeutic Goods Administration)

eryacne

galderma australia pty ltd - erythromycin -

VASTREKA ivermectin 10 mg/g cream tube Austrália - inglês - Department of Health (Therapeutic Goods Administration)

vastreka ivermectin 10 mg/g cream tube

galderma australia pty ltd - ivermectin, quantity: 10 mg/g - cream - excipient ingredients: glycerol; isopropyl palmitate; carbomer copolymer (type b); dimeticone 20; disodium edetate; citric acid monohydrate; cetyl alcohol; stearyl alcohol; ceteareth-20; sorbitan stearate; methyl hydroxybenzoate; propyl hydroxybenzoate; phenoxyethanol; propylene glycol; oleyl alcohol; sodium hydroxide; purified water - vastreka is indicated for the topical treatment of inflammatory lesions of rosacea (papulo-pustular) in adult patients 18 years and over.

DESOWEN Desonide 0.5mg/g ointment tube Austrália - inglês - Department of Health (Therapeutic Goods Administration)

desowen desonide 0.5mg/g ointment tube

galderma australia pty ltd - desonide, quantity: 0.5 mg/g - ointment - excipient ingredients: liquid paraffin; polyethylene - desowen ointment 0.05% is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses for adults and children aged 2 years and older.